BIONTECH (Brazil) Performance
| B1NT34 Stock | BRL 34.12 0.12 0.35% |
The firm shows a Beta (market volatility) of 0.21, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BIONTECH's returns are expected to increase less than the market. However, during the bear market, the loss of holding BIONTECH is expected to be smaller as well. At this point, BIONTECH SE DRN has a negative expected return of -0.4%. Please make sure to confirm BIONTECH's total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if BIONTECH SE DRN performance from the past will be repeated in the future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days BIONTECH SE DRN has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 1.2 B | |
| Total Cashflows From Investing Activities | -566.1 M |
BIONTECH |
BIONTECH Relative Risk vs. Return Landscape
If you would invest 4,413 in BIONTECH SE DRN on December 24, 2024 and sell it today you would lose (1,001) from holding BIONTECH SE DRN or give up 22.68% of portfolio value over 90 days. BIONTECH SE DRN is generating negative expected returns and assumes 2.7082% volatility on return distribution over the 90 days horizon. Simply put, 24% of stocks are less volatile than BIONTECH, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
BIONTECH Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BIONTECH's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BIONTECH SE DRN, and traders can use it to determine the average amount a BIONTECH's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1472
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | B1NT34 |
Estimated Market Risk
| 2.71 actual daily | 24 76% of assets are more volatile |
Expected Return
| -0.4 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BIONTECH is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BIONTECH by adding BIONTECH to a well-diversified portfolio.
BIONTECH Fundamentals Growth
BIONTECH Stock prices reflect investors' perceptions of the future prospects and financial health of BIONTECH, and BIONTECH fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BIONTECH Stock performance.
| Return On Equity | 0.76 | |||
| Return On Asset | 0.43 | |||
| Profit Margin | 0.56 % | |||
| Operating Margin | 0.68 % | |||
| Current Valuation | 165.09 B | |||
| Shares Outstanding | 3.88 B | |||
| Price To Book | 2.30 X | |||
| Price To Sales | 12.63 X | |||
| Revenue | 18.98 B | |||
| EBITDA | 15.13 B | |||
| Total Debt | 171.6 M | |||
| Book Value Per Share | 76.45 X | |||
| Cash Flow From Operations | 889.7 M | |||
| Earnings Per Share | 13.87 X | |||
| Total Asset | 15.83 B | |||
About BIONTECH Performance
By analyzing BIONTECH's fundamental ratios, stakeholders can gain valuable insights into BIONTECH's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BIONTECH has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BIONTECH has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about BIONTECH SE DRN performance evaluation
Checking the ongoing alerts about BIONTECH for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BIONTECH SE DRN help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BIONTECH SE DRN generated a negative expected return over the last 90 days |
- Analyzing BIONTECH's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BIONTECH's stock is overvalued or undervalued compared to its peers.
- Examining BIONTECH's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BIONTECH's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BIONTECH's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BIONTECH's stock. These opinions can provide insight into BIONTECH's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BIONTECH Stock analysis
When running BIONTECH's price analysis, check to measure BIONTECH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIONTECH is operating at the current time. Most of BIONTECH's value examination focuses on studying past and present price action to predict the probability of BIONTECH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIONTECH's price. Additionally, you may evaluate how the addition of BIONTECH to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |